Co-Authors
This is a "connection" page, showing publications co-authored by Jindrich Cinatl and Martin Michaelis.
Connection Strength
1.564
-
Investigation of the influence of EPs® 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses. Phytomedicine. 2011 Mar 15; 18(5):384-6.
Score: 0.455
-
Differentially conserved amino acid positions may reflect differences in SARS-CoV-2 and SARS-CoV behaviour. Bioinformatics. 2021 Feb 09.
Score: 0.232
-
Aprotinin Inhibits SARS-CoV-2 Replication. Cells. 2020 10 30; 9(11).
Score: 0.228
-
COVID-19-Related Coagulopathy-Is Transferrin a Missing Link? Diagnostics (Basel). 2020 Jul 30; 10(8).
Score: 0.224
-
Development of antiviral therapy for severe acute respiratory syndrome. Antiviral Res. 2005 Jun; 66(2-3):81-97.
Score: 0.078
-
Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus. J Med Chem. 2005 Feb 24; 48(4):1256-9.
Score: 0.077
-
High-dose hydrocortisone reduces expression of the pro-inflammatory chemokines CXCL8 and CXCL10 in SARS coronavirus-infected intestinal cells. Int J Mol Med. 2005 Feb; 15(2):323-7.
Score: 0.076
-
Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines. Biochem Biophys Res Commun. 2005 Jan 28; 326(4):905-8.
Score: 0.076
-
Role of interferons in the treatment of severe acute respiratory syndrome. Expert Opin Biol Ther. 2004 Jun; 4(6):827-36.
Score: 0.073
-
Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication. J Ethnopharmacol. 2008 Oct 30; 120(1):108-11.
Score: 0.024
-
Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors. J Med Chem. 2006 Feb 09; 49(3):1198-201.
Score: 0.021